Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

DNA, mRNA and microRNA are released and circulate in the blood of cancer patients.
Changes in the levels of circulating nucleic acids have been associated with tumour burden …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

Context Tumor recurrence is a major issue for patients with hepatocellular carcinoma (HCC)
following curative liver resection. Objective To investigate the association between …

Liver cirrhosis, the end-stage of every chronic liver disease, is not only the major risk factor
for the development of hepatocellular carcinoma but also a limiting factor for anticancer …

Background and Aims Studies have suggested that tenofovir disoproxil fumarate (TDF)
treatment is associated with a significantly lower risk of hepatocellular carcinoma (HCC) …

Serum hepatitis B virus (HBV) DNA levels can fluctuate markedly during the course of
chronic HBV infection. Both case‐control and cohort studies have shown a significant, dose …

Purpose To compare retrospectively the effects of percutaneous radiofrequency (RF)
ablation with those of hepatic resection in the treatment of hepatocellular carcinoma (HCC) …

Infection is a well-described cause of cancer in humans. Being one of the most common
infections worldwide, hepatitis B virus (HBV) is the leading cause of hepatocellular …